https://www.selleckchem.com/pr....oducts/dinaciclib-sc
The technical success rate was 100%. The average procedural time was 53.8±12.8 min. Complications included one case of the access-site pseudoaneurysm, which was successfully treated by thrombin injection. During a median follow-up of 20.5 months (range 6-33 months), all stents remained patent, without endoleak or ulcer recurrence. Conclusions BeGraft stents used during endovascular treatment of abdominal PAU and PUIA lesions are associated with favorable outcomes regarding technical success and patency. The primary use of B
Like
Comment
Share
